Records containing: Hypoparathyroidism
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-22A Phase 3, Multicenter, Randomized, Open-Label Trial Investigating the Safety, Tolerability and Efficacy of Palopegteriparatide Administered Subcutaneously Daily at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2026-04-20An Expanded Cohort Study on the Safety and Efficacy of mRNA Nucleic Acid Drug XH-02 in Treating Adult Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2026-04-17A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
-
CLINICAL_TRIALS study record update · 2026-04-15Efficacy and Safety of Subcutaneous Injection of mRNA Nucleic Acid Drug XH-02 in the Treatment of Adult Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2026-03-27Efficacy and Safety of mRNA Drug XH02 in the Treatment of Adult Hypoparathyroidism
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-20A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of MBX 2109 in Patients With Hypoparathyroidism (Avail Study)
-
CLINICAL_TRIALS study record update · 2026-03-04Comparing Pump vs. Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2026-03-02A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding
-
CLINICAL_TRIALS study record update · 2026-02-27Parathyroid Allotransplant for Treatment of Hypoparathyroidism: PATTH
-
CLINICAL_TRIALS study record update · 2026-02-17A Phase 1b, Open-label, Partially Randomised Study to Assess Safety and Compare Pharmacokinetics of New Oral hPTH(1-34) Tablet Formulations vs. Oral EBP05 Tablets and Subcutaneous Forteo® Injection in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2026-02-09Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-26Real-World Data for Effectiveness and Safety of Palopegteriparatide in Patients With Chronic Hypoparathyroidism in Greece
-
CLINICAL_TRIALS study record update · 2026-01-22Quantitative Testing of Patient and Healthcare Provider Knowledge, Attitudes, and Behavior About NATPARA® (Parathyroid Hormone) for Injection, for Subcutaneous Use
-
CLINICAL_TRIALS study record update · 2026-01-16PaTHway CHINA TRIAL: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial, With an Open-Label Extension, Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Subcutaneously Daily in Adults With Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2025-12-16Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral Metabolism
-
CLINICAL_TRIALS study record update · 2025-11-21Diagnostic Value of Immediate Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy: A Retrospective Observational Study
-
CLINICAL_TRIALS study record update · 2025-11-14Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
-
CLINICAL_TRIALS study record update · 2025-10-28An Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism Who Completed the 12-Week Treatment Period in the Phase 2 Study, MBX-2H1002 Study (Avail-Ext)
-
CLINICAL_TRIALS study record update · 2025-09-29PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2025-09-08Translation and Validation of the Hypoparathyroidism Patient Experience Scales (HPES) Questionnaire in Patients With Hypoparathyroidism for Use in the Greek Population
-
CLINICAL_TRIALS study record update · 2025-09-04A Phase 2, Prospective, Multinational, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of AMOR-1 as a Treatment of Hypocalcemia Associated With Hypoparathyroidism by Replacement of Currently Used Calcium Supplements (CS) in Adults.
-
CLINICAL_TRIALS study record update · 2025-08-08Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
-
CLINICAL_TRIALS study record update · 2025-08-05Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2025-07-11Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism
-
CLINICAL_TRIALS study record update · 2025-06-27Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism